https://www.forbes.com/sites/joshuacohen/2024/11/05/promising-schizophrenia-drug-cobenfy-will-likely-face-access-challenges
Cobenfy (xanomeline/trospium chloride; formerly KarXT) was approved for schizophrenia in adults by the Food and Drug Administration in late September. The drug has a novel mechanism of action, which is the first for schizophrenia in several decades. Cobenfy targets cholinergic receptors instead of balancing levels of dopamine and serotonin, which is what conventional atypical antipsychotics
Promising Schizophrenia Drug, Cobenfy, Will Face Access Challenges
More from BusinessMore posts in Business »
- What’s The Future Of Political Memes As Donald Trump Wins Election?
- Why The Crypto Market Is Surging Today?
- Breaking: Buterin Deposits 2.09M STRK Worth $799K Into Binance
- Shiba Inu Burn Rate Surges Over 3,600% in 24 Hours!
- 4 Projects Actively Shaping the Future of the Blockchain Industry: Top Picks for Long-Term Investors4 Projects Actively Shaping the Future of the Blockchain Industry: Top Picks for Long-Term Investors
- The 18 Best Hotels In Tulum 2024
- Polymarket’s $3.2 Billion Election Bet Shows Web3 Potential
- Inside The Overlooked History Of Election Cakes And The Women Who Made Them
- Best Recliners 2024
- US green power demand expected to grow regardless of election outcome
More from UncategorizedMore posts in Uncategorized »
- What’s The Future Of Political Memes As Donald Trump Wins Election?
- Why The Crypto Market Is Surging Today?
- Breaking: Buterin Deposits 2.09M STRK Worth $799K Into Binance
- Shiba Inu Burn Rate Surges Over 3,600% in 24 Hours!
- 4 Projects Actively Shaping the Future of the Blockchain Industry: Top Picks for Long-Term Investors4 Projects Actively Shaping the Future of the Blockchain Industry: Top Picks for Long-Term Investors
- The 18 Best Hotels In Tulum 2024
- Polymarket’s $3.2 Billion Election Bet Shows Web3 Potential
- Inside The Overlooked History Of Election Cakes And The Women Who Made Them
- Best Recliners 2024
- US green power demand expected to grow regardless of election outcome